Research ArticleClinical Investigations
Assessment of Cellular Proliferation in Tumors by PET Using 18F-ISO-1
Farrokh Dehdashti, Richard Laforest, Feng Gao, Kooresh I. Shoghi, Rebecca L. Aft, Brian Nussenbaum, Friederike H. Kreisel, Nancy L. Bartlett, Amanda Cashen, Nina Wagner-Johnson and Robert H. Mach
Journal of Nuclear Medicine March 2013, 54 (3) 350-357; DOI: https://doi.org/10.2967/jnumed.112.111948
Farrokh Dehdashti
1Divisions of Nuclear Medicine and Radiological Sciences, Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
2The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
Richard Laforest
1Divisions of Nuclear Medicine and Radiological Sciences, Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
2The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
Feng Gao
2The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
3Division of Biostatistics, Washington University School of Medicine, St. Louis, Missouri
Kooresh I. Shoghi
1Divisions of Nuclear Medicine and Radiological Sciences, Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
2The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
Rebecca L. Aft
2The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
4Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Brian Nussenbaum
2The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
4Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
Friederike H. Kreisel
2The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
5Department of Pathology, Washington University School of Medicine, St. Louis, Missouri; and
Nancy L. Bartlett
2The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
6Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
Amanda Cashen
2The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
6Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
Nina Wagner-Johnson
2The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
6Department of Medicine, Washington University School of Medicine, St. Louis, Missouri
Robert H. Mach
1Divisions of Nuclear Medicine and Radiological Sciences, Edward Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, Missouri
2The Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, Missouri
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 54, Issue 3
March 1, 2013
Assessment of Cellular Proliferation in Tumors by PET Using 18F-ISO-1
Farrokh Dehdashti, Richard Laforest, Feng Gao, Kooresh I. Shoghi, Rebecca L. Aft, Brian Nussenbaum, Friederike H. Kreisel, Nancy L. Bartlett, Amanda Cashen, Nina Wagner-Johnson, Robert H. Mach
Journal of Nuclear Medicine Mar 2013, 54 (3) 350-357; DOI: 10.2967/jnumed.112.111948
Assessment of Cellular Proliferation in Tumors by PET Using 18F-ISO-1
Farrokh Dehdashti, Richard Laforest, Feng Gao, Kooresh I. Shoghi, Rebecca L. Aft, Brian Nussenbaum, Friederike H. Kreisel, Nancy L. Bartlett, Amanda Cashen, Nina Wagner-Johnson, Robert H. Mach
Journal of Nuclear Medicine Mar 2013, 54 (3) 350-357; DOI: 10.2967/jnumed.112.111948
Jump to section
Related Articles
Cited By...
- Breast Cancer 18F-ISO-1 Uptake as a Marker of Proliferation Status
- Chemokine receptor 2-targeted molecular imaging in pulmonary fibrosis
- Cell-Proliferation Imaging for Monitoring Response to CDK4/6 Inhibition Combined with Endocrine-Therapy in Breast Cancer: Comparison of [18F]FLT and [18F]ISO-1 PET/CT
- Novel Strategies for Breast Cancer Imaging: New Imaging Agents to Guide Treatment
- The Use of Novel PET Tracers to Image Breast Cancer Biologic Processes Such as Proliferation, DNA Damage and Repair, and Angiogenesis
- Interrogating Tumor Metabolism and Tumor Microenvironments Using Molecular Positron Emission Tomography Imaging. Theranostic Approaches to Improve Therapeutics